NCT03268473

Brief Summary

The main objective of this study is to compare the effect of the non-surgical periodontal treatment on serum and saliva oxidative stress parameters in patients with periodontitis and obstructive sleep apnea syndrome (OSAS) and in patients with periodontitis only.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2017

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 22, 2017

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 31, 2017

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2023

Completed
Last Updated

February 28, 2024

Status Verified

February 1, 2024

Enrollment Period

6.1 years

First QC Date

August 22, 2017

Last Update Submit

February 27, 2024

Conditions

Keywords

OSASObstructive Sleep ApneaPeriodontitis

Outcome Measures

Primary Outcomes (10)

  • Serum Total Antioxidant Status (TAS) level (millimolar per liter (mmol /L))

    Changes in serum and salivary oxidative stress parameters

    3 months

  • Serum Total Oxidant Status (TOS) level (mikromolar per liter (µmol /L))

    Changes in serum and salivary oxidative stress parameters

    3 months

  • Serum Oxidative Stress Index (OSI) level : TOS/TAS

    Changes in serum and salivary oxidative stress parameters

    3 months

  • Serum Native Thiol (mikromolar per liter (µmol /L))

    Changes in serum and salivary oxidative stress parameters

    3 months

  • Serum Thiol/disulfid (millimolar per liter (mmol /L))

    Changes in serum and salivary oxidative stress parameters

    3 months

  • Saliva Total Antioxidant Status (TAS) level (millimolar per liter (mmol /L))

    Changes in serum and salivary oxidative stress parameters

    3 months

  • Saliva Total Oxidant Status (TOS) level (mikromolar per liter (µmol /L))

    Changes in serum and salivary oxidative stress parameters

    3 months

  • Saliva Oxidative Stress Index (OSI) level : TOS/TAS

    Changes in serum and salivary oxidative stress parameters

    3 months

  • Saliva Native Thiol (mikromolar per liter (µmol /L))

    Changes in serum and salivary oxidative stress parameters

    3 months

  • Saliva Thiol/disulfid (millimolar per liter (mmol /L))

    Changes in serum and salivary oxidative stress parameters

    3 months

Secondary Outcomes (5)

  • Plaque Index (PI)

    3 months

  • Gingival Index (GI)

    3 months

  • Bleeding on probing (BOP)

    3 months

  • Clinical attachment loss(CAL)

    3 months

  • Probing pocket depth (PD)

    3 months

Study Arms (2)

Experimental: Non-surgical periodontal therapy in patient with OSAS and Periodontitis

EXPERIMENTAL

Non-surgical periodontal therapy consisted of scaling and root planing and supportive periodontal therapy during 3 months Individuals: with both OSAS and periodontitis Intervention: Procedure: Non-surgical periodontal therapy

Other: Experimental

Control: non-surgical periodontal therapy in Periodontitis

ACTIVE COMPARATOR

Non-surgical periodontal therapy consisted of scaling and root planing and supportive periodontal therapy during 3 months Individuals: only periodontitis Intervention: Procedure: Non-surgical periodontal therapy

Other: Control

Interventions

Experimental: Non-surgical periodontal therapy in patient with OSAS and Periodontitis

Experimental: Non-surgical periodontal therapy in patient with OSAS and Periodontitis
ControlOTHER

Control: Non-surgical periodontal therapy in Periodontitis

Control: non-surgical periodontal therapy in Periodontitis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • aged ≥18 years old
  • having more than 16 teeth
  • BMI\>25 kg/m2

You may not qualify if:

  • patients with a history of diabetes mellitus or respiratory diseases
  • patients who were under any medication that was known to influence periodontal tissues
  • patients with a history of any periodontal treatment in the past 6 months
  • patients with hormonal changes such as pregnancy or lactation; and 5) patients having fixed dentures or removable prothesis
  • OSAS treatment started (using OSAS therapy device or undergoing surgical operation)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bezmialem Vakıf University, Faculty of Dentistry, Deparment of Periodontology,

Istanbul, 34093, Turkey (Türkiye)

Location

Related Publications (3)

  • Loke W, Girvan T, Ingmundson P, Verrett R, Schoolfield J, Mealey BL. Investigating the association between obstructive sleep apnea and periodontitis. J Periodontol. 2015 Feb;86(2):232-43. doi: 10.1902/jop.2014.140229. Epub 2014 Oct 9.

    PMID: 25299385BACKGROUND
  • Gamsiz-Isik H, Kiyan E, Bingol Z, Baser U, Ademoglu E, Yalcin F. Does Obstructive Sleep Apnea Increase the Risk for Periodontal Disease? A Case-Control Study. J Periodontol. 2017 May;88(5):443-449. doi: 10.1902/jop.2016.160365. Epub 2016 Nov 18.

  • DPTT study group; Engebretson S, Gelato M, Hyman L, Michalowicz BS, Schoenfeld E. Design features of the Diabetes and Periodontal Therapy Trial (DPTT): a multicenter randomized single-masked clinical trial testing the effect of nonsurgical periodontal therapy on glycosylated hemoglobin (HbA1c) levels in subjects with type 2 diabetes and chronic periodontitis. Contemp Clin Trials. 2013 Nov;36(2):515-26. doi: 10.1016/j.cct.2013.09.010. Epub 2013 Sep 27.

MeSH Terms

Conditions

PeriodontitisSleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic DiseasesSleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Officials

  • Zeliha Betul Özsağır

    Bezmialem VU

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: It's an assessor blinded, parallel group, randomized controlled trial aimed at investigate whether non-surgical periodontal treatment on serum and saliva oxidative stress parameters in patients with periodontitis and obstructive sleep apnea syndrome (OSAS) and in patients with periodontitis only.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 22, 2017

First Posted

August 31, 2017

Study Start

July 1, 2017

Primary Completion

August 1, 2023

Study Completion

November 1, 2023

Last Updated

February 28, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations